Hospitals and nursing homes will get permission for increasing their bed strength on the condition that these beds will be used only for admitting fever and dengue patients, a senior official said in a statement.
To tackle dengue outbreak, the government said it has also decided to restrict the sale of drugs like "Aspirin, Ibuprofen and Diclofenac" group of medicines which cause "destruction of platelets" in human blood. These will now be sold strictly against prescription by a registered medical practitioner.
"To keep Dengue treatment affordable, the government has put a ceiling on NSI Ag (Elisa based) and Elisa MAC tests at Rs 600 and for platelet count at Rs 50. Any private hospital or lab which charges more than the fixed ceiling price for dengue testing and platelet count will face action," the official said.
The government is also aiming to increase the number of dedicated fever clinics from 55 last year to 355. All hospitals have been advised to have "fever corners" which will function round-the-clock.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
